- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Elk1 Luciferase Reporter Plasmid |
| Catalog No. | RESK-0297 |
| Description | The Elk1 Luciferase Reporter Plasmid (ELK1-Luc) is a reporter gene plasmid designed to detect ELK1 transcriptional activity levels. Elk1 (ETS domain-containing protein) is a ternary complex factor of the ETS family. It plays important roles in a variety of physiological activities, including long-term memory formation, drug addiction, Alzheimer's disease, Down syndrome, breast cancer, and depression. The the vector plasmid is an engineered mammalian eukaryotic expression vector with multiple ELK1 binding sites inserted into its multiple cloning site, enabling highly sensitive detection of ELK1 activation. Predicted binding sites for other transcription factors in the vector have been appropriately mutated to increase transcription factor binding specificity. The reduced plasmid size makes the ELK1 reporter plasmid easier to transfect. |
| Intended Use | Research on the MAPK signaling pathway; drug research; studies of the regulation and function of related genes. |
| Principle / Technology | Multiple tandem ELK1 binding sites cloned upstream of a minimal promoter (PTA) drive expression of the firefly luciferase reporter gene; luciferase activity is proportional to ELK1 transcriptional activity. |
| Detection Method | Luciferase reporter gene assay: after transient transfection into mammalian cells, firefly luciferase activity is measured by luminescence to quantify transcription factor activation. |
| Sample Type | Cultured mammalian cells |
| Performance Range / Specifications | Reporter: firefly luciferase (Luc) Response element: multiple tandem ELK1 binding sites Vector backbone: PGL-6-TA Reporter promoter: PTA (minimal promoter) Resistance gene promoter: SV40 Concentration: approximately 100 ng/uL Supplied amount: 1 μg |
| Sensitivity / LOD | High-sensitivity detection of transcription factor activation levels. |
| Specificity | Predicted binding sites for transcription factors other than the target factor in the vector have been appropriately mutated, increasing transcription factor binding specificity while preserving the original function. |
| Components / Formulation | Engineered mammalian eukaryotic expression plasmid (PGL-6-TA backbone) carrying multiple tandem ELK1 binding sites cloned into the multiple cloning site, upstream of the minimal PTA promoter driving the firefly luciferase reporter gene; the resistance marker is driven by the SV40 promoter. The reduced plasmid size facilitates transfection. |
| Storage Conditions | Store at -20 °C. |
| Package Specifications | 1 μg |
| Product Form | Plasmid DNA in liquid form |
| Quality Control | The full plasmid sequence is verified to be correct (sequence-confirmed). No functional assay validation has been performed; users may refer to relevant literature. |
| Concentration | Approximately 100 ng/uL. |
| Source / Origin | Engineered mammalian eukaryotic expression vector. |
| Shipping Conditions | Shipped with ice packs at low temperature. |
| Regulatory / Compliance | For research use only. Not for use in diagnostic or therapeutic procedures. |
| Compatibility | For use in mammalian cells only (e.g., human, mouse). Compatible with standard plasmid transfection procedures per the transfection reagent used. |
| Application Notes / Precautions | Recommended for transient transfection; stable transfection is not recommended. The supplied 1 μg plasmid is not intended for direct use; amplification by transformation into competent cells (e.g., DH5a) followed by culture and plasmid extraction is recommended. A Luciferase Reporter Plasmid negative control is recommended as the negative control; the positive control should be selected by the user based on relevant literature. |
| Recognition Site | Multiple tandem ELK1 binding sites. |
For research use only, not for clinical use.
|
There is no product in your cart. |